Literature DB >> 29119594

Uniform national guidelines do not prevent wide variations in the clinical application of phototherapy for neonatal jaundice.

Khalaf Mreihil1,2, Britt Nakstad1,2, Hans Jørgen Stensvold2,3, Jūratė Šaltytė Benth2,4, Thor Willy Ruud Hansen2,3.   

Abstract

AIM: This study compared the use of phototherapy for neonatal jaundice in all 21 Norwegian neonatal intensive care units (NICUs) from 2013-2014 to improve practice.
METHODS: Information on all types of phototherapy devices was collected, and irradiance was measured from random units at 20 cm and 50 cm from the light source. We gathered information on local practice rules, including the use of single, double or triple phototherapy, how infants were positioned, the frequency of blood sampling, rules for using reflective surfaces and interrupting phototherapy. In every NICU, we asked one nurse with more than five years of experience and one with less than one year to set up phototherapy equipment, then measured the irradiance and distance.
RESULTS: Photodiodes were the most common of the eight types of phototherapy devices used. Rules for the distance from the device to the infant varied from 10 to 40 cm and in practice they varied from 15 to 48 cm, with irradiance ranging from 11.1-56.1 W/m2 . There were significant variations between NICUs with regard to the overall treatment duration and duration in most birthweight categories.
CONCLUSION: There were considerable variations in phototherapy practices among Norwegian NICUs. In particular, the significant variations in duration need to be addressed. ©2017 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Clinical guidelines, Hyperbilirubinaemia; Neonatal jaundice; Phototherapy; Quality assurance

Mesh:

Year:  2017        PMID: 29119594     DOI: 10.1111/apa.14142

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

1.  Exploration of the pathogenic factors of neonatal jaundice and the clinical effect of blue phototherapy.

Authors:  Bixin Yu; Fangqi Hu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion.

Authors:  Emel Okulu; Omer Erdeve; Ilknur Kilic; Ozgur Olukman; Sebnem Calkavur; Gokhan Buyukkale; Merih Cetinkaya; Dilek Ulubas; Nihal Demirel; Deniz Hanta; Sabahattin Ertugrul; Nazli Dilay Gultekin; Oguz Tuncer; Nihat Demir; Leyla Bilgin; Nejat Narli; Duran Yildiz; Demet Terek; Ozge Altun Koroglu; Canan Seren; Elif Ozyazici; Ramazan Ozdemir; Hatice Turgut; Fatma Narter; Yasemin Akin; Ahmet Ozyazici; Aysegul Zenciroglu; Huseyin Selim Asker; Zeynel Gokmen; Musa Salihli; Ali Bulbul; Umut Zubarioglu; Begum Atasay; Esin Koc
Journal:  Front Pediatr       Date:  2022-04-28       Impact factor: 3.418

3.  The Turkish Neonatal Jaundice Online Registry: A national root cause analysis.

Authors:  Omer Erdeve; Emel Okulu; Ozgur Olukman; Dilek Ulubas; Gokhan Buyukkale; Fatma Narter; Gaffari Tunc; Begum Atasay; Nazli Dilay Gultekin; Saadet Arsan; Esin Koc
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.